aluates Reports

$ 0.0

Automative

Sevoflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Published Date: August 2025

Report Code: QYRE-Auto-30X8684

BUY CHAPTERS

Sevoflurane- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-30X8684

Report

August 2025

Pages:94

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Baxter

Maruishi

Hengrui

AbbVie

Piramal

Viatris

PT Novell Pharmaceutical

Lunan Pharma

Sevoflurane- Market Size

The global market for Sevoflurane was estimated to be worth US$ 1195 million in 2024 and is forecast to a readjusted size of US$ 1527 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.

Sevoflurane- Market

Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.

The key driver for the Sevoflurane market is the increasing number of surgeries worldwide, driven by the aging population and the rising prevalence of chronic conditions requiring surgical intervention. Sevoflurane is highly preferred due to its rapid onset and recovery, making it ideal for both pediatric and adult patients, particularly in outpatient surgeries. Technological advancements in anesthesia delivery systems and the growing demand for minimally invasive procedures have also contributed to the rising adoption of Sevoflurane in clinical settings. Furthermore, the safety and effectiveness of Sevoflurane in maintaining stable cardiovascular function during anesthesia have enhanced its demand.

One of the main challenges in the Sevoflurane market is its high cost compared to other anesthetic agents, which can limit its accessibility in low- and middle-income regions. Additionally, environmental concerns regarding the use of volatile anesthetics like Sevoflurane, which contribute to greenhouse gas emissions, have led to increased scrutiny and calls for more sustainable alternatives. Regulatory restrictions and the availability of generic alternatives may further impact the market growth, as healthcare providers seek more cost-effective or environmentally friendly options.

This report aims to provide a comprehensive presentation of the global market for Sevoflurane, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sevoflurane by region & country, by Type, and by Application.

The Sevoflurane market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sevoflurane.

Market Segmentation

Scope of Sevoflurane- Market Report

Report Metric	Details
Report Name	Sevoflurane- Market
Forecasted market size in 2031	US$ 1527 million
CAGR	3.6%
Forecasted years	2025 - 2031
Segment by Type	Generic Drug Original Drug
Segment by Application	Hospital Clinics Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Hengrui, Baxter, Maruishi, AbbVie, Piramal, Viatris, PT Novell Pharmaceutical, Lunan Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sevoflurane manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Sevoflurane in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Sevoflurane in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Sevoflurane- Market size in 2031?

Ans: The Sevoflurane- Market size in 2031 will be US$ 1527 million.

Who are the main players in the Sevoflurane- Market report?

Ans: The main players in the Sevoflurane- Market are Hengrui, Baxter, Maruishi, AbbVie, Piramal, Viatris, PT Novell Pharmaceutical, Lunan Pharma

What are the Application segmentation covered in the Sevoflurane- Market report?

Ans: The Applications covered in the Sevoflurane- Market report are Hospital, Clinics, Other

What are the Type segmentation covered in the Sevoflurane- Market report?

Ans: The Types covered in the Sevoflurane- Market report are Generic Drug, Original Drug

Recommended Reports

Anesthetic Agent Markets

Respiratory Device Markets

Sedation & Monitoring

1 Market Overview

1.1 Sevoflurane Product Introduction

1.2 Global Sevoflurane Market Size Forecast

1.2.1 Global Sevoflurane Sales Value (2020-2031)

1.2.2 Global Sevoflurane Sales Volume (2020-2031)

1.2.3 Global Sevoflurane Sales Price (2020-2031)

1.3 Sevoflurane Market Trends & Drivers

1.3.1 Sevoflurane Industry Trends

1.3.2 Sevoflurane Market Drivers & Opportunity

1.3.3 Sevoflurane Market Challenges

1.3.4 Sevoflurane Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Sevoflurane Players Revenue Ranking (2024)

2.2 Global Sevoflurane Revenue by Company (2020-2025)

2.3 Global Sevoflurane Players Sales Volume Ranking (2024)

2.4 Global Sevoflurane Sales Volume by Company Players (2020-2025)

2.5 Global Sevoflurane Average Price by Company (2020-2025)

2.6 Key Manufacturers Sevoflurane Manufacturing Base and Headquarters

2.7 Key Manufacturers Sevoflurane Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Sevoflurane

2.9 Sevoflurane Market Competitive Analysis

2.9.1 Sevoflurane Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Sevoflurane Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sevoflurane as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Generic Drug

3.1.2 Original Drug

3.2 Global Sevoflurane Sales Value by Type

3.2.1 Global Sevoflurane Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Sevoflurane Sales Value, by Type (2020-2031)

3.2.3 Global Sevoflurane Sales Value, by Type (%) (2020-2031)

3.3 Global Sevoflurane Sales Volume by Type

3.3.1 Global Sevoflurane Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Sevoflurane Sales Volume, by Type (2020-2031)

3.3.3 Global Sevoflurane Sales Volume, by Type (%) (2020-2031)

3.4 Global Sevoflurane Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinics

4.1.3 Other

4.2 Global Sevoflurane Sales Value by Application

4.2.1 Global Sevoflurane Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Sevoflurane Sales Value, by Application (2020-2031)

4.2.3 Global Sevoflurane Sales Value, by Application (%) (2020-2031)

4.3 Global Sevoflurane Sales Volume by Application

4.3.1 Global Sevoflurane Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Sevoflurane Sales Volume, by Application (2020-2031)

4.3.3 Global Sevoflurane Sales Volume, by Application (%) (2020-2031)

4.4 Global Sevoflurane Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Sevoflurane Sales Value by Region

5.1.1 Global Sevoflurane Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Sevoflurane Sales Value by Region (2020-2025)

5.1.3 Global Sevoflurane Sales Value by Region (2026-2031)

5.1.4 Global Sevoflurane Sales Value by Region (%), (2020-2031)

5.2 Global Sevoflurane Sales Volume by Region

5.2.1 Global Sevoflurane Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Sevoflurane Sales Volume by Region (2020-2025)

5.2.3 Global Sevoflurane Sales Volume by Region (2026-2031)

5.2.4 Global Sevoflurane Sales Volume by Region (%), (2020-2031)

5.3 Global Sevoflurane Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Sevoflurane Sales Value, 2020-2031

5.4.2 North America Sevoflurane Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Sevoflurane Sales Value, 2020-2031

5.5.2 Europe Sevoflurane Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Sevoflurane Sales Value, 2020-2031

5.6.2 Asia Pacific Sevoflurane Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Sevoflurane Sales Value, 2020-2031

5.7.2 South America Sevoflurane Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Sevoflurane Sales Value, 2020-2031

5.8.2 Middle East & Africa Sevoflurane Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Sevoflurane Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Sevoflurane Sales Value

6.2.1 Key Countries/Regions Sevoflurane Sales Value, 2020-2031

6.2.2 Key Countries/Regions Sevoflurane Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Sevoflurane Sales Value, 2020-2031

6.3.2 United States Sevoflurane Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Sevoflurane Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Sevoflurane Sales Value, 2020-2031

6.4.2 Europe Sevoflurane Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Sevoflurane Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Sevoflurane Sales Value, 2020-2031

6.5.2 China Sevoflurane Sales Value by Type (%), 2024 VS 2031

6.5.3 China Sevoflurane Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Sevoflurane Sales Value, 2020-2031

6.6.2 Japan Sevoflurane Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Sevoflurane Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Sevoflurane Sales Value, 2020-2031

6.7.2 South Korea Sevoflurane Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Sevoflurane Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Sevoflurane Sales Value, 2020-2031

6.8.2 Southeast Asia Sevoflurane Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Sevoflurane Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Sevoflurane Sales Value, 2020-2031

6.9.2 India Sevoflurane Sales Value by Type (%), 2024 VS 2031

6.9.3 India Sevoflurane Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Hengrui

7.1.1 Hengrui Company Information

7.1.2 Hengrui Introduction and Business Overview

7.1.3 Hengrui Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Hengrui Sevoflurane Product Offerings

7.1.5 Hengrui Recent Development

7.2 Baxter

7.2.1 Baxter Company Information

7.2.2 Baxter Introduction and Business Overview

7.2.3 Baxter Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Baxter Sevoflurane Product Offerings

7.2.5 Baxter Recent Development

7.3 Maruishi

7.3.1 Maruishi Company Information

7.3.2 Maruishi Introduction and Business Overview

7.3.3 Maruishi Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Maruishi Sevoflurane Product Offerings

7.3.5 Maruishi Recent Development

7.4 AbbVie

7.4.1 AbbVie Company Information

7.4.2 AbbVie Introduction and Business Overview

7.4.3 AbbVie Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 AbbVie Sevoflurane Product Offerings

7.4.5 AbbVie Recent Development

7.5 Piramal

7.5.1 Piramal Company Information

7.5.2 Piramal Introduction and Business Overview

7.5.3 Piramal Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Piramal Sevoflurane Product Offerings

7.5.5 Piramal Recent Development

7.6 Viatris

7.6.1 Viatris Company Information

7.6.2 Viatris Introduction and Business Overview

7.6.3 Viatris Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Viatris Sevoflurane Product Offerings

7.6.5 Viatris Recent Development

7.7 PT Novell Pharmaceutical

7.7.1 PT Novell Pharmaceutical Company Information

7.7.2 PT Novell Pharmaceutical Introduction and Business Overview

7.7.3 PT Novell Pharmaceutical Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 PT Novell Pharmaceutical Sevoflurane Product Offerings

7.7.5 PT Novell Pharmaceutical Recent Development

7.8 Lunan Pharma

7.8.1 Lunan Pharma Company Information

7.8.2 Lunan Pharma Introduction and Business Overview

7.8.3 Lunan Pharma Sevoflurane Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 Lunan Pharma Sevoflurane Product Offerings

7.8.5 Lunan Pharma Recent Development

8 Industry Chain Analysis

8.1 Sevoflurane Industrial Chain

8.2 Sevoflurane Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Sevoflurane Sales Model

8.5.2 Sales Channel

8.5.3 Sevoflurane Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Baxter

Maruishi

Hengrui

AbbVie

Piramal

Viatris

PT Novell Pharmaceutical

Lunan Pharma

List of Tables

Table 1. Sevoflurane Market Trends

Table 2. Sevoflurane Market Drivers & Opportunity

Table 3. Sevoflurane Market Challenges

Table 4. Sevoflurane Market Restraints

Table 5. Global Sevoflurane Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Sevoflurane Revenue Market Share by Company (2020-2025)

Table 7. Global Sevoflurane Sales Volume by Company (2020-2025) & (K Units)

Table 8. Global Sevoflurane Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Sevoflurane Price by Company (2020-2025) & (US$/Unit)

Table 10. Key Manufacturers Sevoflurane Manufacturing Base and Headquarters

Table 11. Key Manufacturers Sevoflurane Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Sevoflurane

Table 13. Global Sevoflurane Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sevoflurane as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Sevoflurane Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Sevoflurane Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Sevoflurane Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Sevoflurane Sales Market Share in Value by Type (2020-2025)

Table 20. Global Sevoflurane Sales Market Share in Value by Type (2026-2031)

Table 21. Global Sevoflurane Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)

Table 22. Global Sevoflurane Sales Volume by Type (2020-2025) & (K Units)

Table 23. Global Sevoflurane Sales Volume by Type (2026-2031) & (K Units)

Table 24. Global Sevoflurane Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Sevoflurane Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Sevoflurane Price by Type (2020-2025) & (US$/Unit)

Table 27. Global Sevoflurane Price by Type (2026-2031) & (US$/Unit)

Table 28. Global Sevoflurane Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Sevoflurane Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Sevoflurane Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Sevoflurane Sales Market Share in Value by Application (2020-2025)

Table 32. Global Sevoflurane Sales Market Share in Value by Application (2026-2031)

Table 33. Global Sevoflurane Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)

Table 34. Global Sevoflurane Sales Volume by Application (2020-2025) & (K Units)

Table 35. Global Sevoflurane Sales Volume by Application (2026-2031) & (K Units)

Table 36. Global Sevoflurane Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Sevoflurane Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Sevoflurane Price by Application (2020-2025) & (US$/Unit)

Table 39. Global Sevoflurane Price by Application (2026-2031) & (US$/Unit)

Table 40. Global Sevoflurane Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Sevoflurane Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Sevoflurane Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Sevoflurane Sales Value by Region (2020-2025) & (%)

Table 44. Global Sevoflurane Sales Value by Region (2026-2031) & (%)

Table 45. Global Sevoflurane Sales Volume by Region (K Units): 2020 VS 2024 VS 2031

Table 46. Global Sevoflurane Sales Volume by Region (2020-2025) & (K Units)

Table 47. Global Sevoflurane Sales Volume by Region (2026-2031) & (K Units)

Table 48. Global Sevoflurane Sales Volume by Region (2020-2025) & (%)

Table 49. Global Sevoflurane Sales Volume by Region (2026-2031) & (%)

Table 50. Global Sevoflurane Average Price by Region (2020-2025) & (US$/Unit)

Table 51. Global Sevoflurane Average Price by Region (2026-2031) & (US$/Unit)

Table 52. Key Countries/Regions Sevoflurane Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Sevoflurane Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Sevoflurane Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Sevoflurane Sales Volume, (2020-2025) & (K Units)

Table 56. Key Countries/Regions Sevoflurane Sales Volume, (2026-2031) & (K Units)

Table 57. Hengrui Company Information

Table 58. Hengrui Introduction and Business Overview

Table 59. Hengrui Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 60. Hengrui Sevoflurane Product Offerings

Table 61. Hengrui Recent Development

Table 62. Baxter Company Information

Table 63. Baxter Introduction and Business Overview

Table 64. Baxter Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 65. Baxter Sevoflurane Product Offerings

Table 66. Baxter Recent Development

Table 67. Maruishi Company Information

Table 68. Maruishi Introduction and Business Overview

Table 69. Maruishi Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 70. Maruishi Sevoflurane Product Offerings

Table 71. Maruishi Recent Development

Table 72. AbbVie Company Information

Table 73. AbbVie Introduction and Business Overview

Table 74. AbbVie Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 75. AbbVie Sevoflurane Product Offerings

Table 76. AbbVie Recent Development

Table 77. Piramal Company Information

Table 78. Piramal Introduction and Business Overview

Table 79. Piramal Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 80. Piramal Sevoflurane Product Offerings

Table 81. Piramal Recent Development

Table 82. Viatris Company Information

Table 83. Viatris Introduction and Business Overview

Table 84. Viatris Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 85. Viatris Sevoflurane Product Offerings

Table 86. Viatris Recent Development

Table 87. PT Novell Pharmaceutical Company Information

Table 88. PT Novell Pharmaceutical Introduction and Business Overview

Table 89. PT Novell Pharmaceutical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. PT Novell Pharmaceutical Sevoflurane Product Offerings

Table 91. PT Novell Pharmaceutical Recent Development

Table 92. Lunan Pharma Company Information

Table 93. Lunan Pharma Introduction and Business Overview

Table 94. Lunan Pharma Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 95. Lunan Pharma Sevoflurane Product Offerings

Table 96. Lunan Pharma Recent Development

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Sevoflurane Downstream Customers

Table 100. Sevoflurane Distributors List

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Sevoflurane Product Picture

Figure 2. Global Sevoflurane Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Sevoflurane Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Sevoflurane Sales Volume (2020-2031) & (K Units)

Figure 5. Global Sevoflurane Sales Price (2020-2031) & (US$/Unit)

Figure 6. Sevoflurane Report Years Considered

Figure 7. Global Sevoflurane Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Sevoflurane Players Sales Volume Ranking (2024) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Sevoflurane Revenue in 2024

Figure 10. Sevoflurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Generic Drug Picture

Figure 12. Original Drug Picture

Figure 13. Global Sevoflurane Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Sevoflurane Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Sevoflurane Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)

Figure 16. Global Sevoflurane Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Sevoflurane Price by Type (2020-2031) & (US$/Unit)

Figure 18. Product Picture of Hospital

Figure 19. Product Picture of Clinics

Figure 20. Product Picture of Other

Figure 21. Global Sevoflurane Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 22. Global Sevoflurane Sales Value Market Share by Application, 2024 & 2031

Figure 23. Global Sevoflurane Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)

Figure 24. Global Sevoflurane Sales Volume Market Share by Application, 2024 & 2031

Figure 25. Global Sevoflurane Price by Application (2020-2031) & (US$/Unit)

Figure 26. North America Sevoflurane Sales Value (2020-2031) & (US$ Million)

Figure 27. North America Sevoflurane Sales Value by Country (%), 2024 VS 2031

Figure 28. Europe Sevoflurane Sales Value, (2020-2031) & (US$ Million)

Figure 29. Europe Sevoflurane Sales Value by Country (%), 2024 VS 2031

Figure 30. Asia Pacific Sevoflurane Sales Value, (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Sevoflurane Sales Value by Region (%), 2024 VS 2031

Figure 32. South America Sevoflurane Sales Value, (2020-2031) & (US$ Million)

Figure 33. South America Sevoflurane Sales Value by Country (%), 2024 VS 2031

Figure 34. Middle East & Africa Sevoflurane Sales Value, (2020-2031) & (US$ Million)

Figure 35. Middle East & Africa Sevoflurane Sales Value by Country (%), 2024 VS 2031

Figure 36. Key Countries/Regions Sevoflurane Sales Value (%), (2020-2031)

Figure 37. Key Countries/Regions Sevoflurane Sales Volume (%), (2020-2031)

Figure 38. United States Sevoflurane Sales Value, (2020-2031) & (US$ Million)

Figure 39. United States Sevoflurane Sales Value by Type (%), 2024 VS 2031

Figure 40. United States Sevoflurane Sales Value by Application (%), 2024 VS 2031

Figure 41. Europe Sevoflurane Sales Value, (2020-2031) & (US$ Million)

Figure 42. Europe Sevoflurane Sales Value by Type (%), 2024 VS 2031

Figure 43. Europe Sevoflurane Sales Value by Application (%), 2024 VS 2031

Figure 44. China Sevoflurane Sales Value, (2020-2031) & (US$ Million)

Figure 45. China Sevoflurane Sales Value by Type (%), 2024 VS 2031

Figure 46. China Sevoflurane Sales Value by Application (%), 2024 VS 2031

Figure 47. Japan Sevoflurane Sales Value, (2020-2031) & (US$ Million)

Figure 48. Japan Sevoflurane Sales Value by Type (%), 2024 VS 2031

Figure 49. Japan Sevoflurane Sales Value by Application (%), 2024 VS 2031

Figure 50. South Korea Sevoflurane Sales Value, (2020-2031) & (US$ Million)

Figure 51. South Korea Sevoflurane Sales Value by Type (%), 2024 VS 2031

Figure 52. South Korea Sevoflurane Sales Value by Application (%), 2024 VS 2031

Figure 53. Southeast Asia Sevoflurane Sales Value, (2020-2031) & (US$ Million)

Figure 54. Southeast Asia Sevoflurane Sales Value by Type (%), 2024 VS 2031

Figure 55. Southeast Asia Sevoflurane Sales Value by Application (%), 2024 VS 2031

Figure 56. India Sevoflurane Sales Value, (2020-2031) & (US$ Million)

Figure 57. India Sevoflurane Sales Value by Type (%), 2024 VS 2031

Figure 58. India Sevoflurane Sales Value by Application (%), 2024 VS 2031

Figure 59. Sevoflurane Industrial Chain

Figure 60. Sevoflurane Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Sevoflurane Sevoflurane Source Market Research Report 2024

Global Sevoflurane Anesthesia Drugs Market Research Report 2024

Global Inhalation Sevoflurane Anesthesia Drugs Market Research Report 2024

Global Sevoflurane For Inhalation Market Research Report 2024

Global Sevoflurane Source Market Insights Forecast to 2030

Global Desflurane Market Research Report 2024

Inhalation Sevoflurane Anaesthetic Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Inhalation General Anesthesia Drugs Market Research Report 2024

Global Inhalation Anesthesia Drugs Market Research Report 2024

Global Anesthesia Gas Market Research Report 2024

Global Isoflurane Anesthesia Drugs Market Research Report 2024

Global Inhalational Isoflurane Market Research Report 2024

Sevoflurane Anesthesia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Inhalational Anaesthesia Drugs Market Research Report 2024

Global Inhalation Sedatives Market Research Report 2024

Global Sevoflurane and Desflurane Anaesthetics Market Research Report 2025

Global Sevoflurane Anesthesia Vaporizers Market Research Report 2024

Global General Anesthesia Drugs Market Research Report 2025

Global Medical Sevofluran Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions